Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Guillermo Prado-Vazquez"'
Autor:
Lucia Trilla-Fuertes, Guillermo Prado-Vazquez, Angelo Gámez-Pozo, Rocio Lopez-Vacas, Maria Isabel Lumbreras Herrera, Virtudes Soriano, Fernando Garicano, Maria Jose Lecumberri, Maria Rodriguez, Margarita Majem, Elisabeth Perez, Maria Gonzalez-Cao, Juana Oramas, Alejandra Magdaleno, Joaquin Fra, Alfonso Martin, Monica Corral, Teresa Puertolas, Juan Angel Fresno Vara, Enrique Espinosa
Publikováno v:
Cancer Research. 82:5416-5416
Background: Prediction of response to immunotherapy remains an unmet need in the field of advanced melanoma. Methods: Computational analyses, including probabilistic graphical models, sparse k-means, and consensus cluster, were used to characterize m
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::05d529f480afca1b478160c1657f261e
https://doi.org/10.1158/1538-7445.am2022-5416
https://doi.org/10.1158/1538-7445.am2022-5416
Autor:
Lucía Trilla-Fuertes, Angelo Gámez-Pozo, Elena López-Camacho, Guillermo Prado-Vázquez, Andrea Zapater-Moros, Rocío López-Vacas, Jorge M. Arevalillo, Mariana Díaz-Almirón, Hilario Navarro, Paloma Maín, Enrique Espinosa, Pilar Zamora, Juan Ángel Fresno Vara
Publikováno v:
BMC Cancer, Vol 20, Iss 1, Pp 1-11 (2020)
Abstract Background Metabolomics has a great potential in the development of new biomarkers in cancer and it has experiment recent technical advances. Methods In this study, metabolomics and gene expression data from 67 localized (stage I to IIIB) br
Externí odkaz:
https://doaj.org/article/b0992cc46a1c43dca0e68fab2cd0fd3e
Autor:
Lucía Trilla-Fuertes, Angelo Gámez-Pozo, Guillermo Prado-Vázquez, Andrea Zapater-Moros, Mariana Díaz-Almirón, Jorge M. Arevalillo, María Ferrer-Gómez, Hilario Navarro, Paloma Maín, Enrique Espinosa, Álvaro Pinto, Juan Ángel Fresno Vara
Publikováno v:
BMC Cancer, Vol 19, Iss 1, Pp 1-9 (2019)
Abstract Background Muscle-invasive bladder tumors are associated with a high risk of relapse and metastasis even after neoadjuvant chemotherapy and radical cystectomy. Therefore, further therapeutic options are needed and molecular characterization
Externí odkaz:
https://doaj.org/article/f7769092f4564a8fbd2ffab2de8da2f1
Comprehensive Characterization of the Mutational Landscape in Localized Anal Squamous Cell Carcinoma
Autor:
Lucía Trilla-Fuertes, Ismael Ghanem, Joan Maurel, Laura G-Pastrián, Marta Mendiola, Cristina Peña, Rocío López-Vacas, Guillermo Prado-Vázquez, Elena López-Camacho, Andrea Zapater-Moros, Victoria Heredia, Miriam Cuatrecasas, Pilar García-Alfonso, Jaume Capdevila, Carles Conill, Rocío García-Carbonero, Karen E. Heath, Ricardo Ramos-Ruiz, Carlos Llorens, Ángel Campos-Barros, Angelo Gámez-Pozo, Jaime Feliu, Juan Ángel Fresno Vara
Publikováno v:
Translational Oncology, Vol 13, Iss 7, Pp 100778- (2020)
Anal squamous cell carcinoma (ASCC) is a rare neoplasm. Chemoradiotherapy is the standard of care, with no therapeutic advances achieved over the past three decades. Thus, a deeper molecular characterization of this disease is still necessary. We ana
Externí odkaz:
https://doaj.org/article/63d83246fc3d4f4a8991a5fc8d8faaad
Autor:
Lucía Trilla-Fuertes, Natalia Miranda, Daniel Castellano, Rocío López-Vacas, Carlos A Farfán Tello, Guillermo de Velasco, Felipe Villacampa, Elena López-Camacho, Guillermo Prado-Vázquez, Andrea Zapater-Moros, Enrique Espinosa, Juan Ángel Fresno Vara, Álvaro Pinto, Angelo Gámez-Pozo
Publikováno v:
PLoS ONE, Vol 15, Iss 2, p e0229075 (2020)
Renal cell carcinoma comprises a variety of entities, the most common being the clear-cell, papillary and chromophobe subtypes. These subtypes are related to different clinical evolution; however, most therapies have been developed for clear-cell car
Externí odkaz:
https://doaj.org/article/dc7a7ca477c6441f8dccabc57884a4ab
Autor:
Lucía Trilla-Fuertes, Angelo Gámez-Pozo, Jorge M Arevalillo, Rocío López-Vacas, Elena López-Camacho, Guillermo Prado-Vázquez, Andrea Zapater-Moros, Mariana Díaz-Almirón, María Ferrer-Gómez, Hilario Navarro, Paolo Nanni, Pilar Zamora, Enrique Espinosa, Paloma Maín, Juan Ángel Fresno Vara
Publikováno v:
PLoS ONE, Vol 15, Iss 6, p e0234752 (2020)
Breast cancer is a heterogeneous disease. In clinical practice, tumors are classified as hormonal receptor positive, Her2 positive and triple negative tumors. In previous works, our group defined a new hormonal receptor positive subgroup, the TN-like
Externí odkaz:
https://doaj.org/article/23eaa0d381594070b5099351b5225110
Autor:
Angelo Gámez-Pozo, Lucía Trilla-Fuertes, Guillermo Prado-Vázquez, Cristina Chiva, Rocío López-Vacas, Paolo Nanni, Julia Berges-Soria, Jonas Grossmann, Mariana Díaz-Almirón, Eva Ciruelos, Eduard Sabidó, Enrique Espinosa, Juan Ángel Fresno Vara
Publikováno v:
PLoS ONE, Vol 12, Iss 6, p e0178296 (2017)
Triple-negative breast cancer (TNBC) accounts for 15-20% of all breast cancers and usually requires the administration of adjuvant chemotherapy after surgery but even with this treatment many patients still suffer from a relapse. The main objective o
Externí odkaz:
https://doaj.org/article/955fdbbbb31e4e22ad928b6b46bf5feb